Kexing Biopharm Logo

Kexing Biopharm

Develops and produces recombinant protein drugs and micro-ecological preparations.

688136 | Shanghai Stock Exchange

Overview

Corporate Details

ISIN(s):
CNE100006ZG6
LEI:
529900Z34Q1M9A907771
Country:
China
Address:
N/A

Description

Kexing Biopharm is an innovative biopharmaceutical enterprise engaged in the research, development, production, and sales of recombinant protein drugs and micro-ecological preparations. The company focuses on developing treatments for therapeutic areas including kidney diseases, oncology, antiviral therapy, autoimmune disorders, metabolic diseases, and degenerative diseases. A key product in its portfolio is Erythropoietin Injection. Kexing Biopharm maintains a comprehensive quality system that aligns with international standards, covering the entire drug lifecycle from production and quality control to release and transportation, ensuring the continuous and stable manufacturing of safe and effective medicines.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-01 21:05
Kexing Biopharm prasentiert globale Strategie und Kooperationsmoglichkeiten auf…
German 6.4 KB

Automate Your Workflow. Get a real-time feed of all Kexing Biopharm filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Kexing Biopharm

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Kexing Biopharm via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Cyfuse Biomedical K.K. Logo
Develops scaffold-free bio 3D printing technology for tissue and organ fabrication.
Japan
4892
CYTOKINETICS INC Logo
A late-stage biopharma developing drugs for diseases of impaired muscle function.
United States of America
CYTK
CytomX Therapeutics, Inc. Logo
Clinical-stage oncology company developing conditionally activated biologics.
United States of America
CTMX
Cytori Cell Research Institute,Inc. Logo
Develops cell therapy medical devices using a patient's own adipose tissue.
Japan
3750
Daebonglsco.,Ltd Logo
Develops and supplies raw materials for the pharmaceutical, cosmetic, and food industries.
South Korea
078140
DaehanPharmaceutical Logo
Researches, develops, and manufactures human/animal pharma and bio-pharmaceuticals.
South Korea
023910
DAE HWA PHARM CO., LTD Logo
Pharmaceutical firm developing drugs with proprietary drug delivery system technologies.
South Korea
067080
Daesung Microbiological Labs. Co. Ltd Logo
Develops, manufactures, and distributes animal pharmaceuticals and vaccines.
South Korea
036480
DAEWON PHARMACEUTICAL CO.,LTD Logo
Develops and manufactures prescription drugs and finished pharmaceutical products.
South Korea
003220
DAEWOONG CO.,LTD Logo
A holding company in the biotech and healthcare sectors developing pharmaceuticals.
South Korea
003090

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.